| | | | | |
ECF Ellsworth Growth and Income Fund Ltd | €10,5587 | -0,41% | €144,80M | €9,63K | |
SBFG SB Financial Group, Inc. | €22,7051 | -1,62% | €144,39M | €12,17K | |
| €4,8455 | +1,55% | €144,34M | €141,43K | |
QTRX Quanterix Corporation Common Stock | €3,0236 | -0,99% | €143,85M | €359,49K | |
| €3,7480 | +0,00% | €143,73M | €48,43K | |
CTAA ClearThink 1 Acquisition Corp. Class A Ordinary Shares | €8,6370 | +0,15% | €143,32M | €116,25 | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | €8,9450 | +0,10% | €142,71M | €326,46K | |
EDF Virtus Stone Harbor Emerging Markets Income Fund | €4,5408 | +2,19% | €142,71M | €42,56K | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | €1,5009 | -2,81% | €142,60M | €880,69K | |
| €1,7699 | -0,49% | €142,52M | €85,65K | |
APYX Apyx Medical Corporation Common Stock | €3,5745 | +0,00% | €142,12M | €72,04K | |
ARCT Arcturus Therapeutics Holdings Inc. Common Stock | €4,9974 | -2,70% | €142,04M | €231,78K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,8305 | +1,26% | €141,88M | €68,07K | |
MNSB MainStreet Bancshares, Inc. Common Stock | €19,9895 | +0,57% | €141,47M | €30,92K | |
KORE KORE Group Holdings, Inc. | €6,9408 | -13,50% | €141,42M | €104,11 | |
